The use of direct acting oral anticoagulants in patients with COVID-19 infection

• Hauptverfasser: Ragia Aly (Verfasst von), Sachin Gupta (Verfasst von), Balraj Singh (Verfasst von), Parminder Kaur (Verfasst von), Kunhwa Kim (Verfasst von), Sorab Gupta (Verfasst von)
• Format: Buch
• Veröffentlicht: Greater Baltimore Medical Center, 2021-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

The use of direct-acting oral anticoagulants (DOACs) has increased rapidly in the last decade; becoming the mainstay for both the prophylaxis and the treatment of venous thromboembolism in various situations including non-valvular atrial fibrillation, joint replacement surgeries and acute DVT/PE, et...